Hemoglobinopathies
Acute myocardial infarction (AMI) remains a leading cause of morbidity and mortality worldwide. Prompt intervention is crucial for improving outcomes. Various pharmacological agents have been evaluated for their efficacy in AMI management. Among these, tenecteplase has emerged as a noteworthy fibrinolytic agent. It offers potential benefits in this critical condition. The following sections explore its […]
Hemoglobinopathies Read More ยป